Overexpression of RAC2 in Alzheimer's disease brains increased microglia phagocytosis

Authors

  • Libei Zhu

DOI:

https://doi.org/10.54097/yk6y5n95

Keywords:

Alzheimer's disease, microglia, phagocytosis, RAC2.

Abstract

Alzheimer's disease (AD) is a degenerative neurological disease characterized by memory impairment, agnosia, and loss of motor function. Although treatment is available to alleviate symptoms, there is no cure due to limited understanding of its pathogenesis. Amyloid protein amyloid-β (Aβ) is believed to be the core mechanism of disease onset. And several studies reported that Aβ plaque could be effectively cleared by microglia, thereby preventing AD progression. Yet as a double-edged sword, microglia over-activation would cause unexpected neuroinflammation in patients with AD. To understand the dysfunction of microglia in AD, single-cell RNA-sequencing (scRNA-seq) was used to precisely determine the gene expression of microglia populations. Several genes involved phagocytosis showed decreased expression in microglia of AD brains. The upregulated RAC2, a small Rho-GTPase (GTP enzyme), was selected to explore its function in microglia activation. Results from in vitro experiments further revealed the up-regulation of RAC2 in microglia of AD patient may mediate the microglia phagocytosis to Aβ. Therefore, the up-regulation of RAC2 can potentially reduce the level of Aβ protein in AD patients and delay the progression of the disease. We hope that the results of the experiment will provide more helpful information for the treatment of AD.

Downloads

Download data is not yet available.

References

Sonkusare, S. K., Kaul, C. L., & Ramarao, P. (2005). Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope. Pharmacological research, 51(1), 1-17.

Huang, H. C., & Jiang, Z. F. (2009). Accumulated amyloid-β peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. Journal of Alzheimer's disease, 16(1), 15-27.

Colonna, M., & Butovsky, O. (2017). Microglia function in the central nervous system during health and neurodegeneration. Annual review of immunology, 35, 441-468.

Shi, H., Wang, X. L., Quan, H. F., Yan, L., Pei, X. Y., Wang, R., & Peng, X. D. (2019). Effects of betaine on LPS-stimulated activation of microglial M1/M2 phenotypes by suppressing TLR4/NF-κB pathways in N9 cells. Molecules, 24(2), 367.

Tu, H., Chu, H., Guan, S., Hao, F., Xu, N., Zhao, Z., & Liang, Y. (2021). The role of the M1/M2 microglia in the process from cancer pain to morphine tolerance. Tissue and Cell, 68, 101438.

Cai, Z., Hussain, M. D., & Yan, L. J. (2014). Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. International Journal of Neuroscience, 124(5), 307-321.

Franco-Bocanegra, D. K., Gourari, Y., McAuley, C., Chatelet, D. S., Johnston, D. A., Nicoll, J. A., & Boche, D. (2021). Microglial morphology in Alzheimer’s disease and after Aβ immunotherapy. Scientific Reports, 11(1), 15955.

Smith, A. M., Davey, K., Tsartsalis, S., Khozoie, C., Fancy, N., Tang, S. S., ... & Matthews, P. M. (2022). Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology. Acta Neuropathologica, 143(1), 75-91.

Ciudad, S., Puig, E., Botzanowski, T., Meigooni, M., Arango, A. S., Do, J., ... & Carulla, N. (2020). Aβ (1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage. Nature communications, 11(1), 3014.

Mao, Y., & Finnemann, S. C. (2015). Regulation of phagocytosis by Rho GTPases. Small GTPases, 6(2), 89–99.

Cohen, J. L., Ata, A. E., Jackson, N. L., Rahn, E. J., Ramaker, R. C., Cooper, S., ... & Clinton, S. M. (2017). Differential stress induced c-Fos expression and identification of region-specific miRNA-mRNA networks in the dorsal raphe and amygdala of high-responder/low-responder rats. Behavioural brain research, 319, 110-123.

Yu, H., Liu, Y., Li, C., Wang, J., Yu, B., Wu, Q., ... & Feng, S. (2020). Bioinformatic analysis of neuroimmune mechanism of neuropathic pain. BioMed Research International, 2020.

An, M., Qiu, Y., Wang, C., Ma, P., & Ding, Y. (2023). Rac2 enhances activation of microglia and astrocytes, inflammatory response, and apoptosis via activating JNK signaling pathway and suppressing SIRT1 expression in chronic constriction injury-induced neuropathic pain. Journal of Neuropathology & Experimental Neurology, 82(5), 419-426.

13Xiong, M., Zou, L., Meng, L., Zhang, X., Tian, Y., Zhang, G., ... & Zhang, Z. (2021). A γ-adducin cleavage fragment induces neurite deficits and synaptic dysfunction in Alzheimer’s disease. Progress in Neurobiology, 203, 102074.

Downloads

Published

11-07-2024

How to Cite

Zhu, L. (2024). Overexpression of RAC2 in Alzheimer’s disease brains increased microglia phagocytosis. Highlights in Science, Engineering and Technology, 102, 8-16. https://doi.org/10.54097/yk6y5n95